Aa-Risedronate Dr 35 mg (Risedronate Sodium (Risedronate Sodium Hemipentahydrate) TABLET (DELAYED-RELEASE)) 35 MG

AA-Risedronate DR 35 mg is a delayed-release tablet containing risedronate sodium, used to support bone health. This medication is commonly prescribed for conditions related to bone density.

Strength

35 MG

Manufacturer / TM Owner

AA PHARMA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AA-Risedronate DR 35 mg is primarily used to help maintain bone density and strength. It is often prescribed for conditions such as osteoporosis, where the primary goal is to support bone health and reduce the risk of fractures. Risedronate sodium works by slowing down the process of bone breakdown, helping to preserve bone structure.

Side Effects

Common effects of AA-Risedronate DR 35 mg may include gastrointestinal discomfort, such as nausea or stomach pain. Some users might experience heartburn or difficulty swallowing. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

AA-Risedronate DR 35 mg should be taken with a full glass of water, and the tablet should not be crushed or chewed. It is important to stay upright for at least 30 minutes after taking the medication to help it reach the stomach properly. This medication should be taken on an empty stomach, preferably in the morning.

Avoid Interactions

AA-Risedronate DR 35 mg may interact with certain medications, including antacids and other oral supplements. It is advisable to avoid taking other medications within two hours of taking risedronate sodium. Additionally, alcohol consumption should be limited, as it can affect the absorption and effectiveness of the medication.

Frequently Asked Questions

AA-Risedronate DR 35 mg is used to support bone health, particularly in conditions like osteoporosis where maintaining bone density is important.

AA-Risedronate DR 35 mg should be taken with a full glass of water on an empty stomach, preferably in the morning. Avoid lying down for at least 30 minutes after taking the medication.

Common side effects may include gastrointestinal discomfort, nausea, stomach pain, heartburn, and difficulty swallowing. These effects are usually mild and temporary.

It is advisable to avoid taking other medications within two hours of taking AA-Risedronate DR 35 mg, as they can interfere with its absorption.

If you miss a dose, take it the next morning, skipping the missed dose. Do not take a double dose to make up for the missed one.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.